-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Neumora Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2022 to Q3 2025.
- Neumora Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2025 was $5.98M, a 39.9% decline year-over-year.
- Neumora Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2025 was $32.4M, a 10.4% decline year-over-year.
- Neumora Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $40M, a 132% increase from 2023.
- Neumora Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $17.2M, a 108% increase from 2022.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)